Standard Operating Procedure for Post-Approval Change Notification Across Markets
| Department | Regulatory Affairs |
| SOP No. | RA/2026/673 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 11/04/2026 |
| Effective Date | 11/04/2026 |
| Review Date | 11/04/2028 |
Purpose
This Standard Operating Procedure (SOP) provides a structured and controlled approach to notify and manage post-approval changes across multiple regulatory markets. It ensures timely, accurate, and compliant submission of change notifications to regulatory authorities to maintain the approved status of products or processes, supporting regulatory compliance and minimizing business risks associated with unauthorized changes.
Scope
This SOP applies to all post-approval changes including variations, amendments, supplements, and lifecycle management activities related to products, processes, equipment, documentation, or systems handled by the Regulatory Affairs department. It covers changes impacting quality, safety, efficacy, or compliance status across all markets where the company’s products are registered. Changes excluded from this SOP are those managed under separate change control or internal quality systems that do not require regulatory notification.
Responsibilities
The following roles are involved in executing the post-approval change notification process:
- Regulatory Affairs Officer: Prepare and compile necessary documentation for change notification submissions.
- Quality Assurance: Review change assessments and support data integrity verification.
- Change Control Coordinator: Ensure identification and classification of changes requiring notification.
- Regulatory Affairs Manager: Review and approve submission documentation prior to dispatch.
- Compliance Team: Monitor changes for compliance with global regulatory requirements.
Accountability
The Regulatory Affairs Head is accountable for the implementation, compliance, periodic review, escalation of issues, and verification of the ongoing effectiveness of this SOP. This role ensures that all post-approval changes are notified appropriately and that regulatory requirements are met consistently across markets.
Procedure
1. Initiation and Identification: All proposed changes must be documented and assessed through the company’s change control system to establish whether they require regulatory notification across one or multiple markets.
2. Change Impact Assessment: Conduct a comprehensive evaluation of the change’s impact on product quality, safety, efficacy, and compliance using established risk assessment tools. Collaborate with Quality Assurance and other relevant departments to gather supporting data.
3. Regulatory Strategy Determination: Determine the appropriate type of submission (e.g., notification, minor or major variation) for each affected market in accordance with that market’s regulatory guidelines and timelines.
4. Documentation Preparation: Compile all required documentation including change descriptions, rationale, supporting data, updated dossiers, batch records, and certificates of analysis, ensuring accuracy and adherence to regulatory formatting requirements.
5. Review and Approval: Submit documentation to the Regulatory Affairs Manager and Quality Assurance for thorough review and approval. Address any queries or amendments prior to submission.
6. Submission: Forward the approved change notification package to the designated regulatory authorities within stipulated timelines. Use electronic or physical submission modes as required by each authority.
7. Tracking and Monitoring: Record submission details in the regulatory database and monitor acknowledgment, queries, or approval from regulatory bodies. Coordinate responses or additional information provision as necessary.
8. Post-Approval Monitoring: Ensure implementation of the change only after receiving the appropriate regulatory approval or as per the allowed notification pathway. Update internal documents and systems to reflect the change accurately.
9. Deviation Handling: If unauthorized changes or deviations are identified, initiate immediate investigation, notify applicable authorities as required, and implement corrective and preventive actions documented in deviation reports.
10. Record Keeping: Maintain comprehensive and retrievable records of all change notifications, supporting documents, correspondence, approvals, and monitoring activities, in compliance with company and regulatory requirements.
11. Periodic Review: Conduct periodic audits and management reviews of the notification process effectiveness and compliance, implementing improvements as necessary.
Abbreviations
SOP: Standard Operating Procedure
RA: Regulatory Affairs
QA: Quality Assurance
GMP: Good Manufacturing Practice
CAPA: Corrective and Preventive Action
ICH: International Council for Harmonisation
MAH: Marketing Authorization Holder
Documents
The following documents are essential for conducting the post-approval change notification process:
- Post-Approval Change Notification Form (Annexure-1)
- Change Impact Assessment Report (Annexure-2)
- Regulatory Submission Tracking Log (Annexure-3)
References
– ICH Q12: Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
– EMA Guideline on the details of the various categories of variations
– US FDA Guidance for Industry: Changes to an Approved NDA or ANDA
– PIC/S GMP Guide Annex 2
– Company Quality Management System Procedures and Change Control SOP
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Post-Approval Change Notification Form
Purpose: To formally document all details of the post-approval change for submission to relevant regulatory authorities.
| Change Reference Number | PACN-2026-011 |
| Date of Change Proposal | 05/04/2026 |
| Product Name | Example Product X |
| Marketing Authorization Number | MA-123456 |
| Description of Change | Modification of manufacturing site for intermediate synthesis step |
| Reason for Change | Process optimization and cost reduction |
| Impact on Quality/Safety/Efficacy | None anticipated; supported by validation data |
| Regulatory Submission Type | Variation Type II |
| Markets to be Notified | EU, UK, Canada |
| Responsible Person | Regulatory Affairs Officer |
| Signature | ____________________ |
| Date | 07/04/2026 |
Annexure-2: Change Impact Assessment Report
Purpose: To evaluate and document the impact of the proposed post-approval change on product quality, safety, efficacy, and regulatory compliance.
| Assessment Reference | CIA-2026-008 |
| Date of Assessment | 06/04/2026 |
| Change Description | Modification of manufacturing site for intermediate synthesis step |
| Impact on Product Quality | No significant impact; validated scale-up and process controls in place |
| Impact on Safety | None identified |
| Impact on Efficacy | Not affected |
| Supporting Evidence/Documents | Validation reports, stability data, batch records |
| Assessment Conducted By | Quality Assurance Reviewer |
| Signature | ____________________ |
| Date | 06/04/2026 |
Annexure-3: Regulatory Submission Tracking Log
Purpose: To systematically track the status and progress of post-approval change notifications submitted to each regulatory authority.
| Submission ID | Market | Submission Date | Submission Type | Authority Acknowledgement Date | Approval Date | Status | Remarks |
|---|---|---|---|---|---|---|---|
| PACN-2026-011-EU | European Union | 10/04/2026 | Variation Type II | 17/04/2026 | 25/04/2026 | Approved | Approved without queries |
| PACN-2026-011-UK | United Kingdom | 11/04/2026 | Variation Type II | 18/04/2026 | 26/04/2026 | Approved | Minor administrative query resolved |
| PACN-2026-011-CA | Canada | 12/04/2026 | Variation Type II | 19/04/2026 | Pending | Under Review | Additional stability data requested |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 11/04/2026 | 1.0 | Initial issue | New SOP creation |